T2 Biosystems Inc EV/EBITDA
¿Qué es el EV/EBITDA de T2 Biosystems Inc?
El EV/EBITDA de T2 Biosystems Inc es N/A
¿Cuál es la definición de EV/EBITDA?
EV / EBITDA es el valor de la empresa dividido por las ganancias antes de intereses, impuestos, depreciación y amortización. Es una medida de cuál cara es una acción y es más frecuentemente válida para comparaciones entre compañías que la relación precio / ganancias. Mide el precio (en forma de valor empresarial) que un inversionista paga en beneficio del flujo de caja de la compañía (en forma de EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA de compañías en Sector Health Care en NASDAQ en comparadas con T2 Biosystems Inc
¿Qué hace T2 Biosystems Inc?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Empresas con ev/ebitda similar a T2 Biosystems Inc
- Prime Intelligence Solutions tiene EV/EBITDA de N/A
- K.B. Recycling Industries tiene EV/EBITDA de N/A
- Forward Water Technologies tiene EV/EBITDA de N/A
- Fjordland Exploration tiene EV/EBITDA de N/A
- Aquarius AI tiene EV/EBITDA de N/A
- Sipa Resources tiene EV/EBITDA de N/A
- T2 Biosystems Inc tiene EV/EBITDA de N/A
- RightCrowd tiene EV/EBITDA de N/A
- China Strategic tiene EV/EBITDA de N/A
- Deliveroo Plc tiene EV/EBITDA de N/A
- Singulus Technologies AG tiene EV/EBITDA de N/A
- Inventiva S.A tiene EV/EBITDA de N/A
- Pascal Biosciences tiene EV/EBITDA de N/A